Tuesday, June 3, 2025

MarinHealth Surgeons Perform the First Vascular Surgical Procedure for Aneurysm Repair Utilizing Artificial Intelligence (AI) Technology

Related stories

EXL & Databricks launch GenAI tool for code migration

EXL, a leading data and AI-driven company, has deepened...

Aptean Acquisition of VLEX for DACH ERP Reach

Aptean Inc., a global leader in AI-powered enterprise resource...

Portless Raises $18M to Transform Global E-Com & Fulfillment

Portless, a U.S.-based innovator in global e-commerce fulfillment, announced...

Syneris Launches to Disrupt AI with Decentralized Compute

A unified network leveraging underused GPU and CPU resources...

Tenable to Acquire Apex Security to Boost AI Risk Coverage

Tenable Holdings, Inc., the exposure management company, announced its intent...
spot_imgspot_img

MarinHealth announced that it performed its first vascular surgical procedure for aneurysm repair utilizing advanced AI technology. Allan Conway, MD, Clinical Associate Professor of Vascular and Endovascular Surgery, UCSF and MarinHealth, and the vascular surgical team applied Cydar Maps augmented artificial intelligence technology, making the MarinHealth vascular surgical team one of few teams nationwide capable of using this advanced system.

The AI-equipped Cydar Maps surgical platform enables surgeons and clinicians to create a detailed 3D map personalized to each patient’s unique anatomy for pre-surgical planning, real-time image guidance during surgery, and automated post-operative evaluation of surgical outcomes. Cydar Maps not only enhances the surgeon’s visualization but also aids the surgeon’s decision-making in the operating room and helps guide decisions throughout the entire patient care pathway, resulting in better patient outcomes and improved efficiency.

Also Read: An Overview of Revenue Cycle Management Automation

“Integrating Cydar Maps is part of MarinHealth’s ongoing commitment to stay at the forefront of innovative solutions and treatments, providing our community with access to the best treatment options available,” commented David Klein, MD, CEO of MarinHealth.

“This cutting-edge technology empowers surgeons to navigate complex vascular procedures with greater precision. Plus, it provides advanced tools that enable physicians to track aneurysm volume over time,” said Conway. “This is a significant milestone as we aim to revolutionize endovascular aortic treatment with cutting-edge, digital solutions. It empowers surgeons with more knowledge, which ultimately improves patient outcomes.”

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img